原文始发于微信公众号（药时代服务号）：Projects for Licensing | DrugTimes
-
PhaseII Bispecific Antibody Platform and Projects -
PhaseIII Ophthalmology Project (Dry Eye, Postoperative Inflammation/Pain) -
The world’s leading botanical drug R&D company: phase III hair loss products -
PhaseIII First-in-class IAP antagonist for various cancers
If you are interested in these potential collaboration opportunities, please contact us.
More opportunities will be posted, please visit: www.drugtimes.cn
For more opportunities, please click here！发布者：药时代，转载请首先联系contact@drugtimes.cn获得授权
为好文打赏 支持药时代 共创新未来！ 